Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC.

MLA

Paul, Ulrike, et al. “Advanced Patient Age at Diagnosis of Diffuse Large B-Cell Lymphoma Is Associated with Molecular Characteristics Including ABC-Subtype and High Expression of MYC.” Leukemia & Lymphoma, vol. 59, no. 5, May 2018, pp. 1213–21. EBSCOhost, https://doi.org/10.1080/10428194.2017.1365851.

APA

Paul, U., Richter, J., Siebert, R., Nagel, I., Rosenwald, A., Feller, A. C., Cogliatti, S., Stein, H., Hansmann, M.-L., Moller, P., Burkhardt, B., Pfreundschuh, M., Schmitz, N., Stuhlmann-Laiesz, C., Aukema, S. M., Szczepanowski, M., Klapper, W., Trümper, L., Kreuz, M., & Loeffler, M. (2018). Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC. Leukemia & Lymphoma, 59(5), 1213–1221. https://doi.org/10.1080/10428194.2017.1365851

Chicago

Paul, Ulrike, Julia Richter, Reiner Siebert, Inga Nagel, Andreas Rosenwald, Alfred C. Feller, Sergio Cogliatti, et al. 2018. “Advanced Patient Age at Diagnosis of Diffuse Large B-Cell Lymphoma Is Associated with Molecular Characteristics Including ABC-Subtype and High Expression of MYC.” Leukemia & Lymphoma 59 (5): 1213–21. doi:10.1080/10428194.2017.1365851.